and as such, the specific components of the screening programs vary between the provinces 4 .
INTRODUCTION
In 2011, the Pan-Canadian Cervical Cancer Screening Initiative (pccsi), supported by the Canadian Partnership Against Cancer, released Cervical Cancer Screening in Canada: Monitoring Program Performance [2006] [2007] [2008] and for the first time presented information on 12 national quality indicators relating to provincial and territorial cervical cancer screening programs. Among those indicators is the participation rate: the percentage of eligible women who had at least 1 Pap test in a 3-year period. Adequate participation in cervical cancer screening is necessary for screening programs to be successful in reducing mortality from that disease.
CERVICAL CANCER SCREENING IN CANADA
Since the early 1980s, the incidence and mortality of cervical cancer in Canada has declined considerably 1 . Cervical cancer screening by cervical cytology (Pap test) has been the primary reason for the decline. The goal of cervical cancer screening is to detect and treat precancerous lesions early so as to prevent invasive cervical cancer from developing.
Not being screened for cervical cancer at the recommended time interval is a major risk factor for developing cervical cancer 2 . A meta-analysis showed that, on average, 53.8% of women diagnosed with invasive cervical cancer had inadequate screening histories, and of the diagnosed women, 41.5% had never been screened 3 .
In Canada, screening for cervical cancer has been largely opportunistic, although programs are becoming increasingly organized. As of June 2011, organized or partially organized cervical cancer screening programs had been established in 8 provinces, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Nova Scotia, Prince Edward Island, and Newfoundland and Labrador. Screening guidelines and the organization of the screening programs occurs at the provincial level, corrected for hysterectomy, participation varied little across age groups. Participation was lower only for women 60-69 years of age. Provincial and territorial guidelines recommend an end to screening at age 69 (or older in some case). However, guidelines from the U.S. Preventive Services Task Force recommend an end to screening after age 65, provided that women have had adequate recent screening with normal Pap test results 5 .
FUTURE DIRECTIONS
Infection with high-risk types of the human papilloma virus (hpv) causes almost all cases of cervical cancer, with approximately 70% of cases being caused by hpv types 16 and 18 6 . Over the next few years, hpv testing and hpv vaccination programs implemented across the country will have a significant impact on cervical cancer screening guidelines. The pccsi will continue to foster implementation and continuing development of effective cervical cancer screening programs and to focus on integration of screening with hpv vaccination, testing, and surveillance initiatives.
ABOUT THE CERVICAL CANCER SCREENING IN CANADA: MONITORING PROGRAM PERFORMANCE 2006-2008 REPORT
The pccsi serves as a forum for key stakeholders from across the country to discuss and take action on matters related to cervical cancer screening programs and their integration with hpv testing and vaccination initiatives. As part of the pccsi, a working group was formed to coordinate the submission and analysis of baseline cervical cancer screening data and to de- Provincial cervical cancer screening programs contributed data for the inaugural report and reviewed report drafts.
The full report can be viewed at http://www. partnershipagainstcancer.ca/wp-content/uploads/ CPAC_Cervical_CS_Report_E_WEB_Final.pdf. 
